Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- 045569 No ClinicalTrials.gov identifier reported
- 05-001 No ClinicalTrials.gov identifier reported
- (05-625) PRESERVE: Zenith Iliac Branch System Clinical Study No ClinicalTrials.gov identifier reported
- 05-625 Zenith Branch Endovascular Graft-Iliac Bifurcation/Atrium iCAST No ClinicalTrials.gov identifier reported
- 059566 No ClinicalTrials.gov identifier reported
- 060102 - Clinical Trial Phase II (Disease state) No ClinicalTrials.gov identifier reported
- 060104 - Clinical Trial Pase IV (Post Marketing) (Bayer Product or TA) No ClinicalTrials.gov identifier reported
- 060105 - Independent Study Support (Bayer Product or TA) No ClinicalTrials.gov identifier reported
- 060106 - Independent Research Grant (Bayer Product) No ClinicalTrials.gov identifier reported
- 060107 - Investigator Fees or Payments No ClinicalTrials.gov identifier reported
- 060201 - Clinical Trial Phase I (Disease state) No ClinicalTrials.gov identifier reported
- 060202 - Clinical Trial Phase II (Disease state) No ClinicalTrials.gov identifier reported
- 060203 - Clinical Trial Phase III (Disease state) No ClinicalTrials.gov identifier reported
- 060204 - Clinical Trial Pase IV (Post Marketing) (Bayer Product or TA) No ClinicalTrials.gov identifier reported
- 060205 - Independent Study Support (Bayer Product or TA) No ClinicalTrials.gov identifier reported
- 060206 - Independent Research Grant (Bayer Product) No ClinicalTrials.gov identifier reported
- 060207 - Investigator Fees or Payments No ClinicalTrials.gov identifier reported
- 06-254 No ClinicalTrials.gov identifier reported
- 063-020 No ClinicalTrials.gov identifier reported
- 07-003 Fenestrated/P-Branch Single-center study (McKinsey) No ClinicalTrials.gov identifier reported
- (07-003) Zenith AAA Fenestrated and p-Branch Endovascular Graft Single Center Study No ClinicalTrials.gov identifier reported
- 0702: A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma No ClinicalTrials.gov identifier reported
- 0702: A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma (RV-MM-BMTCTN-0494) No ClinicalTrials.gov identifier reported
- 07-100 LPS Flex Mobile PAS No ClinicalTrials.gov identifier reported
- 0761-016 No ClinicalTrials.gov identifier reported
- 07A & 09A Comparators No ClinicalTrials.gov identifier reported
- 07A-Cli-008 Covid 19 No ClinicalTrials.gov identifier reported
- 07A-Cli-009 No ClinicalTrials.gov identifier reported
- (08-005) Zenith TX2 TAA Endovascular Graft Post-Approval Study No ClinicalTrials.gov identifier reported
- (08-013) Zenith Low Profile AAA Endovascular Graft Clinical Study No ClinicalTrials.gov identifier reported
- 091-01 BD Non-GLP AVF Study No ClinicalTrials.gov identifier reported
- 091-04 BD GLP AVF Study No ClinicalTrials.gov identifier reported
- 09A-Cli-001 Covid-Flu No ClinicalTrials.gov identifier reported
- 09DY-02-18G03-01 ARCHITECT CMV IgG DESIGN VALIDATION No ClinicalTrials.gov identifier reported
- (10-001) Zenith TX2 Low Profile TAA Endovascular Graft Study in U.S. and Japan No ClinicalTrials.gov identifier reported
- 100104: A Phase III Randomized, Double-Blind Study of Maintenance Therapy with CC-5013 (NSC # 703813, IND # 70116) or Placebo Following Autologus Stem Cell Transplantation for Multiple Myeloma No ClinicalTrials.gov identifier reported
- 100104: A Phase III Randomized, Double-Blind Study of Maintenance Therapy with CC-5013 (NSC # 703813, IND # 70116) or Placebo Following Autologus Stem Cell Transplantation for Multiple Myeloma (RV-MM-CALGB-0011) No ClinicalTrials.gov identifier reported
- 10073010 No ClinicalTrials.gov identifier reported
- 1009742 NCT03439254
- 100 Analysis : 200 FFRct Analysis : 201 FFRct (Default) No ClinicalTrials.gov identifier reported
- 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 424 PRECISE No ClinicalTrials.gov identifier reported
- 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 437 P3 No ClinicalTrials.gov identifier reported
- 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 438 JACS No ClinicalTrials.gov identifier reported
- 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 442 FFRct ACP No ClinicalTrials.gov identifier reported
- 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 443 ADVANCE-ED No ClinicalTrials.gov identifier reported
- 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 447 REVEALPLAQUE No ClinicalTrials.gov identifier reported
- 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 448 MGH Type 2 MI No ClinicalTrials.gov identifier reported
- 1010016 No ClinicalTrials.gov identifier reported
- 10-106 No ClinicalTrials.gov identifier reported
- 1011386 NCT03633227